StockData
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ) stock

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.53−0.09 (-14.35%)

Close on Nov 13, 2026Market cap $3.48MP/E –Yield –

Earnings

Creative Medical Technology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Creative Medical Technology's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Creative Medical Technology has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Creative Medical Technology puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Creative Medical Technology filed with the SEC as exhibits to Form 8-K or 6-K

  1. Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
    News
  2. Creative Medical Technology Holdings Announces Reverse Stock Split
    News
  3. Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market
    News

See a number that looks wrong?